Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
ACTIVE_NOT_RECRUITING
Status
Conditions
- Acute Myeloid Leukemia
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- Atypical Chronic Myeloid Leukemia
- Chronic Myelomonocytic Leukemia
- Essential Thrombocythemia
- Myelodysplastic/Myeloproliferative Neoplasm
- Myelofibrosis
- Polycythemia Vera
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
Interventions
- DRUG: Carboplatin
- DRUG: Topotecan
- DRUG: Topotecan Hydrochloride
- DRUG: Veliparib
Sponsor
National Cancer Institute (NCI)